Codex Labs has announced the launch of the first product in a new collection, KĀNGFÙ, that is focused on healing damaged skin ...

In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...

The skin on different areas of the body requires different regimens. Here’s how dermatologists recommend treating it on your ...

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

Oct 14th, 2025 - Codex Labs, a Silicon Valley skintech company, has launched KĀNGFÙ Cooling Recovery Gel, a game-changing ...

Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical Development PRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ...

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company's XTR ...

Sustainability is a very important topic in our work, outside of the scientific part of the Congress. It was started as a ...

Personalized dosing strategies may be necessary for biologic therapies, especially fixed-dose options like ustekinumab, due ...

Adults with worse cardiovascular-kidney-metabolic health are at an increased risk of developing psoriasis, especially in those with high genetic risk.

Patients with psoriasis face higher risk for several different types of cancer, according to the results of an international study.